• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促进青光眼治疗中患者的依从性。

Facilitating patient compliance in glaucoma therapy.

作者信息

Zimmerman T J, Zalta A H

出版信息

Surv Ophthalmol. 1983 Dec;28 Suppl:252-8. doi: 10.1016/0039-6257(83)90142-x.

DOI:10.1016/0039-6257(83)90142-x
PMID:6665702
Abstract

Noncompliance is a major problem in glaucoma therapy. The causes, forms, and sociological variables associated with noncompliance are reviewed. A comprehensive strategy to facilitate the safe and effective use of glaucoma medications is presented and discussed. This strategy combines education about the disease and its treatment, "tailoring" of the therapeutic regimen, training and reinforcement in eyedrop application, cooperation with primary care physicians, alleviating side effects, and improving doctor-patient relationships.

摘要

不依从性是青光眼治疗中的一个主要问题。本文回顾了与不依从性相关的原因、形式和社会学变量。并提出和讨论了一项促进青光眼药物安全有效使用的综合策略。该策略包括对疾病及其治疗的教育、治疗方案的“个性化”、滴眼液使用的培训与强化、与初级保健医生的合作、减轻副作用以及改善医患关系。

相似文献

1
Facilitating patient compliance in glaucoma therapy.促进青光眼治疗中患者的依从性。
Surv Ophthalmol. 1983 Dec;28 Suppl:252-8. doi: 10.1016/0039-6257(83)90142-x.
2
[Improved eyedrop administration and compliance in glaucoma patients. A clinical study].[青光眼患者滴眼液给药方式的改进及依从性:一项临床研究]
Klin Monbl Augenheilkd. 1997 Oct;211(4):257-62. doi: 10.1055/s-2008-1035132.
3
[Patient compliance in glaucoma therapy].
Ophthalmologe. 2002 Dec;99(12):964-72. doi: 10.1007/s00347-002-0719-5.
4
A glaucoma medication time-table card.
Ann Ophthalmol. 1987 Feb;19(2):43-4.
5
A comprehensive perspective on patient adherence to topical glaucoma therapy.关于患者对局部青光眼治疗依从性的全面观点。
Ophthalmology. 2009 Nov;116(11 Suppl):S30-6. doi: 10.1016/j.ophtha.2009.06.024.
6
Multicenter study of compliance and drop administration in glaucoma.青光眼治疗依从性与滴眼液使用的多中心研究。
Can J Ophthalmol. 2008 Aug;43(4):454-61. doi: 10.1139/i08-076.
7
[Compliance in glaucoma].[青光眼的依从性]
Oftalmologia. 2008;52(3):7-9.
8
Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment.患者与眼科医生对青光眼治疗中依从性和给药的态度。
J Ocul Pharmacol Ther. 2004 Dec;20(6):461-9. doi: 10.1089/jop.2004.20.461.
9
Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study.青光眼患者药物治疗方案依从性不佳的原因:一项定性研究。
J Ocul Pharmacol Ther. 2002 Oct;18(5):401-9. doi: 10.1089/10807680260362687.
10
Introduction: new insights on enhancing adherence to topical glaucoma medications.引言:提高局部青光眼药物依从性的新见解
Ophthalmology. 2009 Nov;116(11 Suppl):S29. doi: 10.1016/j.ophtha.2009.06.026.

引用本文的文献

1
Improving Adherence to Topical Medication in Patients with Glaucoma.提高青光眼患者局部用药的依从性
Patient Prefer Adherence. 2021 Jul 2;15:1477-1489. doi: 10.2147/PPA.S264926. eCollection 2021.
2
Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs.溴莫尼定和噻吗洛尔局部给药后在兔体内的眼内及全身药代动力学:固定组合制剂与单一药物的比较
Ophthalmol Ther. 2020 Mar;9(1):115-125. doi: 10.1007/s40123-020-00229-x. Epub 2020 Jan 17.
3
European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.
《欧洲青光眼协会青光眼术语与指南》第4版 - 第3章:治疗原则与选择 由欧洲青光眼协会基金会支持:第1部分:前言;引言;术语表;第3章治疗原则与选择
Br J Ophthalmol. 2017 Jun;101(6):130-195. doi: 10.1136/bjophthalmol-2016-EGSguideline.003.
4
Topical medication instillation techniques for glaucoma.青光眼的局部用药滴注技术
Cochrane Database Syst Rev. 2017 Feb 20;2(2):CD010520. doi: 10.1002/14651858.CD010520.pub2.
5
Barriers to Glaucoma Medication Compliance Among Veterans: Dry Eye Symptoms and Anxiety Disorders.退伍军人青光眼药物治疗依从性的障碍:干眼症状和焦虑症
Eye Contact Lens. 2018 Jan;44(1):50-54. doi: 10.1097/ICL.0000000000000301.
6
Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination.固定剂量他氟前列素/噻吗洛尔组合相对于固定剂量拉坦前列素/噻吗洛尔组合的疗效和安全性优势。
PLoS One. 2016 Jul 6;11(7):e0158797. doi: 10.1371/journal.pone.0158797. eCollection 2016.
7
Strategies to Improve Glaucoma Compliance Based on Cross-Sectional Response-Based Data in a Tertiary Healthcare Center: The Glauco-Jung Study.基于三级医疗中心横断面反应数据的青光眼依从性改善策略:青光眼-荣格研究
J Curr Glaucoma Pract. 2015 May-Aug;9(2):38-46. doi: 10.5005/jp-journals-10008-1182. Epub 2015 Sep 25.
8
How 'Drug Aware' are our Glaucoma Patients?我们的青光眼患者对“药物知晓”程度如何?
J Curr Glaucoma Pract. 2015 May-Aug;9(2):33-7. doi: 10.5005/jp-journals-10008-1181. Epub 2015 Sep 25.
9
Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.老年青光眼患者治疗中的药物治疗与依从性问题
Drugs Aging. 2015 Jul;32(7):569-81. doi: 10.1007/s40266-015-0282-9.
10
Patient acceptance to smartphone technology to monitor and improve glaucoma health-care outcomes.
Eye (Lond). 2014 Apr;28(4):496. doi: 10.1038/eye.2014.22. Epub 2014 Feb 14.